Navigation Links
Clarient to Present at Canaccord Adams 29th Annual Global Growth Conference on Wednesday, August 12th
Date:8/5/2009

ALISO VIEJO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make an investor presentation at the Canaccord Adams 29th Annual Global Growth Conference at 8:00 am EDT on Wednesday, August 12, 2009. The conference will be held at the InterContinental Boston Hotel, August 11-13, 2009.

A live webcast of the presentation will be available via a link provided at http://www.clarientinc.com/investor. An archived replay of the presentation will be available for a period of 90 days from the date of the presentation.

About Clarient

Clarient combines innovative diagnostic technologies with world class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by dedicating itself to collaborative relationships with the healthcare community to translate cancer discovery and research into better patient care. The Company's principal customers include pathologists, oncologists, hospitals and biopharmaceutical companies. The rise of individualized medicine as the new direction in oncology has created the need for a centralized resource providing leading diagnostic technologies, such as flow cytometry and molecular testing. Clarient is that resource, having created a state-of-the-art commercial cancer laboratory providing advanced oncology testing and diagnostic services available both onsite and over the web. The Company is also developing new, proprietary "companion" diagnostic markers for therapeutics in breast, prostate, lung and colon cancers, and leukemia/lymphoma. www.clarientinc.com

    Investor Contact:
    Matt Clawson
    Allen & Caron Inc
    (949) 474-4300
    matt@allencaron.com


'/>"/>
SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Clarient Reports Second Quarter Revenue Up 40 Percent
2. Clarient Set to Join Russell 3000 Index
3. Clarient Launches New Gene Mutation Test to Help Select Therapy for Non-Small Cell Lung Cancer
4. Clarient Reports 41% Revenue Increase for First Quarter 2009
5. Clarient Launches New Breast Cancer Test
6. Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners
7. Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day
8. Clarient Renews and Expands Mezzanine Credit Facility With Safeguard
9. Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays
10. Clarient Reports First Quarter 2008
11. Clarient to Present at the B. Riley & Co. 9th Annual Las Vegas Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , ... May 04, 2016 , ... ... developers and operators of commercial real estate proudly announced that its service-based charitable ... initiative. Team members portfolio-wide will continue Olshan Properties’ annual philanthropic tradition in ...
(Date:5/4/2016)... LA (PRWEB) , ... May 04, 2016 , ... Hight-Doland ... LA area has teamed up with Big Brothers Big Sisters of Southwest Louisiana to ... being accepted here . , Big Brothers Big Sisters of Southwest Louisiana has ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Dr. Elyson and ... tooth removal surgery at their office. Wisdom tooth removal, a common dental procedure, is ... problematic, they often are improperly erupted, resulting in risks of complications. By providing wisdom ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Natalie Jill ... with local company MitoXcell in preparation of the launch of her new book: Natalie ... plan is a nutritional guide designed to jump start a new healthy lifestyle featuring ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator ... and compliance. In upcoming months, AudioEducator has lined up some informative training session ... designed to give complete compliance know-how and practical, easy-to-apply advice. , On Thursday, ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute Ischemic Stroke Market and ... their offering.       (Logo: ... Acute Ischemic Stroke Market and Competitive Landscape ... Ischemic Stroke pipeline products, Acute Ischemic Stroke ...
(Date:5/4/2016)... 2016 Research and ... Acute lymphocytic Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Lymphocytic Leukemia epidemiology, Acute Lymphocytic ...
(Date:5/3/2016)... -- Research and Markets has announced the ... Market Outlook 2020" report to their offering. ... technology has improved significantly in past years due to ... coming years. Many cancer drugs have been developed by ... also expected to be developed with its help. They ...
Breaking Medicine Technology: